X CHIOME - Trademark Details
Status: 700 - Registered
Serial Number
79169641
Registration Number
5126156
Word Mark
X CHIOME
Status
700 - Registered
Status Date
2017-01-24
Filing Date
2015-04-28
Registration Number
5126156
Registration Date
2017-01-24
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261121 - Rectangles that are completely or partially shaded.
Published for Opposition Date
2016-11-08
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
MAHONEY, PAULA M
Statements
Indication of Colors claimed
The color(s) blue and white is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a stylized "X" in white, within a blue square. Centered below the "X" is the term "CHIOME" in blue.
Goods and Services
Monoclonal antibodies for medical or veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; peptides and proteins for medical or veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; biological and chemical preparations and reagents for medical or veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; medicines for human purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; medicines for dental purposes, namely, for infectious diseases, neurological diseases or inflammatory diseases; medicines for veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; medicinal preparations, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; living cells for manufacturing monoclonal antibodies used for medical purposes; cell lines for manufacturing monoclonal antibodies used for medical purposes; living cells for manufacturing monoclonal antibodies used for veterinary purposes; cell lines for manufacturing monoclonal antibodies used for veterinary purposes; biological tissue cultures for medical purposes, namely, for cultivating living cells or cell lines used for manufacturing monoclonal antibodies; dietary supplements for humans; nutritional supplements; dietary supplements for animals; dietetic foods, namely, protein adapted for medical purposes; dietetic beverages, namely, protein-based ready to drink beverages adapted for medical purposes; food for babies; powdered milk for babies; lacteal flour for babies; surgical implants comprised of living tissues; biological implants, namely, a vital processed human or animal connective tissue; disinfectants for hygiene purposes; sanitary sterilising preparations; biocides; preparations for destroying vermin
Goods and Services
Research, product development and quality control services in the field of proteins, antibodies, microorganisms and cells, and consultancy relating thereto; research and development services in the field of antibody technology; biomedical research services; design and development of medical technology; research and development in the field of biotechnology; pharmaceutical research and development; conducting clinical trials for others in the field of pharmaceutical products; clinical trials for others; technical project studies in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical research in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical project planning in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; research and development of new products for others; design and development of computer software for use with medical technology; software design and development; providing temporary use of non-downloadable business software; rental of computer software; cloud computing featuring software used for development of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-08-06
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2015-08-06
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Corporation).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Corporation).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Corporation).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Corporation).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
M. Scott Alprin
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1258037
International Registration Date
2015-04-28
International Publication Date
2015-07-30
International Renewal Date
2025-04-28
Auto Protection Date
2017-01-30
International Status
001 - Request for extension of protection established
International Status Date
2015-07-30
Priority Claimed In
True
Priority Claimed Date
2015-03-04
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2015-07-30 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2015-08-06 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2015-08-08 | ASSIGNED TO EXAMINER |
| 2015-08-11 | APPLICATION FILING RECEIPT MAILED |
| 2015-08-13 | NON-FINAL ACTION WRITTEN |
| 2015-08-14 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2015-08-14 | REFUSAL PROCESSED BY MPU |
| 2015-08-14 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2015-09-04 | REFUSAL PROCESSED BY IB |
| 2016-02-15 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2016-02-15 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2016-02-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2016-02-19 | ASSIGNED TO LIE |
| 2016-02-25 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2016-02-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2016-03-17 | NON-FINAL ACTION WRITTEN |
| 2016-03-17 | NON-FINAL ACTION E-MAILED |
| 2016-03-17 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2016-09-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2016-09-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2016-09-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2016-09-24 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2016-10-03 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2016-10-19 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2016-10-19 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2016-10-19 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2016-11-08 | PUBLISHED FOR OPPOSITION |
| 2016-11-08 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2017-01-04 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 2017-01-04 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2017-01-06 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 2017-01-24 | REGISTERED-PRINCIPAL REGISTER |
| 2017-04-24 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2017-04-25 | FINAL DISPOSITION PROCESSED |
| 2017-04-25 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2017-05-12 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2017-08-04 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 2022-01-24 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
